electroCore (ECOR) Notes Payables (2017 - 2026)

electroCore's (ECOR) quarterly Notes Payables came in at $250000.0 in Q1 2026, down 54.17% quarter-over-quarter from $545551.0 in Q1 2021.

electroCore (ECOR) Notes Payables (2017 - 2026) Analysis & Trends

electroCore's Notes Payables history runs 5 years deep, the most recent figure standing at $250000.0 for Q1 2026.

On a quarterly basis, Notes Payables changed N/A year-over-year to $250000.0 in Q1 2026; TTM through Mar 2026 was $250000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $311354.0, up 178.3% from the prior year.
Notes Payables fell to $250000.0 in Q1 2026 per ECOR's latest filing, from $545551.0 in the prior quarter.
Across five years, Notes Payables topped out at $250000.0 in Q1 2026 and bottomed at $250000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	electroCore	56,941.08	-8.77 Mn	8.36 Mn

Download Data